Literature DB >> 18828416

Patient risks, outcomes, and costs of voluntary HIV testing at five testing sites within a medical center.

Supriya D Mehta1, Jonathan Hall, Jeffrey L Greenwald, Kevin Cranston, Paul R Skolnik.   

Abstract

OBJECTIVES: The Centers for Disease Control and Prevention (CDC) recommends offering human immunodeficiency virus (HIV) testing to all patients in all high HIV-prevalence clinical settings. We evaluated programmatic aspects of HIV testing across multiple clinical settings within a single medical center.
METHODS: We analyzed programmatic data of HIV testing in the Urgent Care Center (UCC), inpatient floors, outpatient primary care, a non-clinical Drop-In Center, and Emergency Department (ED). HIV testing was by oral mucosal transudate, venous blood samples, or rapid testing fingersticks, with Western blot confirmation. We compared the sociodemographics and behavioral risks of individuals undergoing HIV testing across the five sites and estimated costs per person tested and per HIV-positive test result.
RESULTS: From 2002 to 2004, 16,750 HIV tests were conducted, with 229 (1.4%) previously unreported HIV infections diagnosed among 16,696 valid test results. HIV-positive prevalence was 1.5% for the UCC, 1.5% at the Drop-In Center, 1.4% for primary care, 1.2% for inpatient, and 0.6% in the ED. Behavioral risks were most prevalent in the UCC and the Drop-In Center. The cost per test was lowest in the UCC and highest in the Drop-In Center. The cost per previously unreported HIV infection was lowest in the UCC ($1,980) and highest in the ED ($9,724).
CONCLUSIONS: Although a significant number of HIV infections were identified, the number of tests performed represents < 10% of all clinical visits. Due to personnel and time constraints, offering HIV testing to patients hierarchically in some settings of a high-volume medical center merits evaluation.

Entities:  

Mesh:

Year:  2008        PMID: 18828416      PMCID: PMC2496934          DOI: 10.1177/003335490812300511

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  18 in total

1.  Risk behaviors and HIV incidence among repeat testers at publicly funded HIV testing sites in San Francisco.

Authors:  Susan E Fernyak; Kimberly Page-Shafer; Timothy A Kellogg; William McFarland; Mitchell H Katz
Journal:  J Acquir Immune Defic Syndr       Date:  2002-09-01       Impact factor: 3.731

2.  Voluntary HIV testing as part of routine medical care--Massachusetts, 2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-06-25       Impact factor: 17.586

3.  Routinely recommended HIV testing at an urban urgent-care clinic--Atlanta, Georgia, 2000.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-06-29       Impact factor: 17.586

4.  Factors associated with unrecognized HIV-1 infection in an inner-city emergency department.

Authors:  P L Alpert; J Shuter; M G DeShaw; M P Webber; R S Klein
Journal:  Ann Emerg Med       Date:  1996-08       Impact factor: 5.721

5.  Identifying undiagnosed human immunodeficiency virus: the yield of routine, voluntary inpatient testing.

Authors:  Rochelle P Walensky; Elena Losina; Kathleen A Steger-Craven; Kenneth A Freedberg
Journal:  Arch Intern Med       Date:  2002-04-22

6.  Acute human immunodeficiency virus infection in patients presenting to an urban urgent care center.

Authors:  Jonathan M Pincus; Sondra S Crosby; Elena Losina; Erin R King; Colleen LaBelle; Kenneth A Freedberg
Journal:  Clin Infect Dis       Date:  2003-11-17       Impact factor: 9.079

7.  Advancing HIV prevention: new strategies for a changing epidemic--United States, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-04-18       Impact factor: 17.586

8.  HIV testing in a resource-poor urban emergency department.

Authors:  Nancy R Glick; Abigail Silva; Leslie Zun; Steven Whitman
Journal:  AIDS Educ Prev       Date:  2004-04

9.  Emergency department-based HIV screening and counseling: experience with rapid and standard serologic testing.

Authors:  G D Kelen; J B Shahan; T C Quinn
Journal:  Ann Emerg Med       Date:  1999-02       Impact factor: 5.721

10.  Costs and consequences of the US Centers for Disease Control and Prevention's recommendations for opt-out HIV testing.

Authors:  David R Holtgrave
Journal:  PLoS Med       Date:  2007-06       Impact factor: 11.069

View more
  7 in total

1.  PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.

Authors:  Debbie L Seem; Ingi Lee; Craig A Umscheid; Matthew J Kuehnert
Journal:  Public Health Rep       Date:  2013-07       Impact factor: 2.792

Review 2.  Cost-effectiveness analysis and HIV screening: the emergency medicine perspective.

Authors:  Heather Hsu; Rochelle P Walensky
Journal:  Ann Emerg Med       Date:  2011-07       Impact factor: 5.721

3.  HIV screening practices in U.S. hospitals, 2009-2010.

Authors:  Andrew C Voetsch; James D Heffelfinger; Juliet Yonek; Pragna Patel; Steven F Ethridge; Gretchen W Torres; Margaret A Lampe; Bernard M Branson
Journal:  Public Health Rep       Date:  2012 Sep-Oct       Impact factor: 2.792

Review 4.  Epidemiology of HIV infection in the United States: implications for linkage to care.

Authors:  Richard D Moore
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 9.079

5.  Risk behavior disclosure during HIV test counseling.

Authors:  Elizabeth Ann Torrone; James C Thomas; Suzanne Maman; Audrey E Pettifor; Jay S Kaufman; Arlene C Sena; Lisa B Hightow-Weidman
Journal:  AIDS Patient Care STDS       Date:  2010-09       Impact factor: 5.078

6.  Cost-effectiveness of strategies to improve HIV testing and receipt of results: economic analysis of a randomized controlled trial.

Authors:  Gillian D Sanders; Henry D Anaya; Steven Asch; Tuyen Hoang; Joya F Golden; Ahmed M Bayoumi; Douglas K Owens
Journal:  J Gen Intern Med       Date:  2010-03-04       Impact factor: 5.128

7.  Geographic information system-based screening for TB, HIV, and syphilis (GIS-THIS): a cross-sectional study.

Authors:  Neela D Goswami; Emily J Hecker; Carter Vickery; Marshall A Ahearn; Gary M Cox; David P Holland; Susanna Naggie; Carla Piedrahita; Ann Mosher; Yvonne Torres; Brianna L Norton; Sujit Suchindran; Paul H Park; Debbie Turner; Jason E Stout
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.